| 1. |
|
|
| 2. |
- Abe, O, et al.
(författare)
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
- 2005
-
Ingår i: The Lancet. - 1474-547X. ; 365:9472, s. 1687-1717
-
Tidskriftsartikel (refereegranskat)abstract
- Background Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5-year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year effects. Methods Collaborative meta-analyses were undertaken of 194 unconfounded randomised trials of adjuvant chemotherapy or hormonal therapy that began by 1995. Many trials involved CMF (cyclophosphamide, methotrexate, fluorouracil), anthracycline-based combinations such as FAC (fluorouracil, doxombicin, cyclophosphamide) or FEC (fluorouracil, epirubicin, cyclophosphamide), tamoxifen, or ovarian suppression: none involved taxanes, trastuzumab, raloxifene, or modem aromatase inhibitors. Findings Allocation to about 6 months of anthracycline-based polychemotherapy (eg, with FAC or FEC) reduces the annual breast cancer death rate by about 38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4) for those of age 50-69 years when diagnosed, largely irrespective of the use of tamoxifen and of oestrogen receptor (ER) status, nodal status, or other tumour characteristics. Such regimens are significantly (2p=0 . 0001 for recurrence, 2p<0 . 00001 for breast cancer mortality) more effective than CMF chemotherapy. Few women of age 70 years or older entered these chemotherapy trials. For ER-positive disease only, allocation to about 5 years of adjuvant tamoxifen reduces the annual breast cancer death rate by 31% (SE 3), largely irrespective of the use of chemotherapy and of age (<50, 50-69, &GE; 70 years), progesterone receptor status, or other tumour characteristics. 5 years is significantly (2p<0 . 00001 for recurrence, 2p=0 . 01 for breast cancer mortality) more effective than just 1-2 years of tamoxifen. For ER-positive tumours, the annual breast cancer mortality rates are similar during years 0-4 and 5-14, as are the proportional reductions in them by 5 years of tamoxifen, so the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis. These results combine six meta-analyses: anthracycline-based versus no chemotherapy (8000 women); CMF-based versus no chemotherapy (14 000); anthracycline-based versus CMF-based chemotherapy (14 000); about 5 years of tamoxifen versus none (15 000); about 1-2 years of tamoxifen versus none (33 000); and about 5 years versus 1-2 years of tamoxifen (18 000). Finally, allocation to ovarian ablation or suppression (8000 women) also significantly reduces breast cancer mortality, but appears to do so only in the absence of other systemic treatments. For middle-aged women with ER-positive disease (the commonest type of breast cancer), the breast cancer mortality rate throughout the next 15 years would be approximately halved by 6 months of anthracycline-based chemotherapy (with a combination such as FAC or FEC) followed by 5 years of adjuvant tamoxifen. For, if mortality reductions of 38% (age <50 years) and 20% (age 50-69 years) from such chemotherapy were followed by a further reduction of 31% from tamoxifen in the risks that remain, the final mortality reductions would be 57% and 45%, respectively (and, the trial results could well have been somewhat stronger if there had been full compliance with the allocated treatments). Overall survival would be comparably improved, since these treatments have relatively small effects on mortality from the aggregate of all other causes. Interpretation Some of the widely practicable adjuvant drug treatments that were being tested in the 1980s, which substantially reduced 5-year recurrence rates (but had somewhat less effect on 5-year mortality rates), also substantially reduce 15-year mortality rates. Further improvements in long-term survival could well be available from newer drugs, or better use of older drugs.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Nordborg, M, et al.
(författare)
-
The pattern of polymorphism in Arabidopsis thaliana
- 2005
-
Ingår i: PLoS Biology. - : Public Library of Science (PLoS). - 1545-7885. ; 3:7, s. 1289-1299
-
Tidskriftsartikel (refereegranskat)abstract
- We resequenced 876 short fragments in a sample of 96 individuals of Arabidopsis thaliana that included stock center accessions as well as a hierarchical sample from natural populations. Although A. thaliana is a selfing weed, the pattern of polymorphism in general agrees with what is expected for a widely distributed, sexually reproducing species. Linkage disequilibrium decays rapidly, within 50 kb. Variation is shared worldwide, although population structure and isolation by distance are evident. The data fail to fit standard neutral models in several ways. There is a genome-wide excess of rare alleles, at least partially due to selection. There is too much variation between genomic regions in the level of polymorphism. The local level of polymorphism is negatively correlated with gene density and positively correlated with segmental duplications. Because the data do not fit theoretical null distributions, attempts to infer natural selection from polymorphism data will require genome-wide surveys of polymorphism in order to identify anomalous regions. Despite this, our data support the utility of A. thaliana as a model for evolutionary functional genomics.
|
|
| 6. |
- Peng, Ru, 1960-, et al.
(författare)
-
Crystal structure and phase transformation in Ni53Mn 25Ga22 shape memory alloy from 20 K to 473 K
- 2005
-
Ingår i: Applied Physics Letters. - : AIP Publishing. - 0003-6951 .- 1077-3118. ; 87:11
-
Tidskriftsartikel (refereegranskat)abstract
- The crystal structures, magnetic structures, and phase transformation of the off-stoichiometric Ni53 Mn25 Ga22 were studied by neutron powder diffraction at different temperatures. It is shown that Ni53 Mn25 Ga22 has a tetragonal I4/mmm structure from 20 K to 403 K. An abrupt jump in unit-cell volume around room temperature, corresponding to an endothermic peak in the differential scanning calorimetry curve, was observed. This indicates a pretransformation in the martensitic phase of Ni53 Mn25 Ga22, which is completely different from the phase transformation in the stoichiometric Ni2 MnGa. The sequence of structural transformation in Ni53 Mn25 Ga22 is closely related to its intrinsic temperature-dependent magnetic structure. © 2005 American Institute of Physics.
|
|
| 7. |
- Sun, Y. H., et al.
(författare)
-
Theoretical studies on nonlinear optical properties of two newly synthesized compounds : EPVPC and OPVPC
- 2005
-
Ingår i: Chinese Physics. - : IOP Publishing. - 1009-1963 .- 1741-4199. ; 14:1, s. 115-119
-
Tidskriftsartikel (refereegranskat)abstract
- The nonlinear optical properties of two newly synthesized molecules 9-Ethyl-3-{2-[4-(2-Pyridin-4-yl-vinyl)-phenyl]vinyl}-9H-carbazole (EPVPC) and 9-Octadecyl-3-{2-[4-(2-Pyridin-4-yl-vinyl)-phenyl]-vinyl}-9H-carbazole (OPVPC) have been studied with hybrid density functional theory (DFT/B3LYP). The generalized few-state model is employed to calculate the two-photon absorption cross sections of the compounds. The theoretical results are in good agreement with the available experimental measurements. It is found that the maximal two-photon absorption (TPA) cross sections of the compounds can be well described by a three-state model. The numerical simulation shows that both compounds have large two-photon absorption (TPA) cross sections and, furthermore, OPVPC displays a little stronger TPA activity than EPVPC in a lower frequency region.
|
|
| 8. |
- Zhao, L. Y., et al.
(författare)
-
Nanotubes from isomeric dibenzoylmethane molecules
- 2005
-
Ingår i: Chemistry - A European Journal. - : Wiley. - 0947-6539 .- 1521-3765. ; 11:12, s. 3773-3778
-
Tidskriftsartikel (refereegranskat)abstract
- Organic nanotubes of various diameters were fabricated from the isomeric molecule dibenzoylmethane (DBM) by using an immersing technique with ordered porous alumina membrane as the template. The ratio of the enol isomers of DBM increased as the diameters of the nanotubes decreased. In addition, although almost no fluorescence could be detected for the DBM monomer, a striking enhancement in the fluorescence emission intensity of the nanotubes was observed as the diameters decreased. This is due to the increased ratio of the enol isomers.
|
|
| 9. |
- Zhao, Zhi, et al.
(författare)
-
Experimental realization of optimal asymmetric cloning and telecloning via partial teleportation
- 2005
-
Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 95:3, s. 030502-
-
Tidskriftsartikel (refereegranskat)abstract
- We report an experimental realization of both optimal asymmetric cloning and telecloning of single photons by making use of partial teleportation of an unknown state. In the experiment, we demonstrate that, conditioned on the success of partial teleportation of single photons, not only the optimal asymmetric cloning can be accomplished, but also one of two outputs can be transferred to a distant location, realizing the telecloning. The experimental results represent a novel way to achieve quantum cloning and may have potential applications in the context of quantum communication.
|
|
| 10. |
|
|
